Skip to main content
PMC home page
The BMJ logoLink to The BMJ
letter
. 1990 Jan 6;300(6716):48–49. doi: 10.1136/bmj.300.6716.48-d

Treatment protocols, specialist centers, and end results.

C A Stiller
PMCID: PMC1661857  PMID: 2105137

Full text

PDF
48

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gill M., McCarthy M., Murrells T., Silcocks P. Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years. Lancet. 1988 Mar 26;1(8587):689–692. doi: 10.1016/s0140-6736(88)91485-7. [DOI] [PubMed] [Google Scholar]
  2. Karjalainen S., Palva I. Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland. BMJ. 1989 Oct 28;299(6707):1069–1072. doi: 10.1136/bmj.299.6707.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kramer S., Meadows A. T., Pastore G., Jarrett P., Bruce D. Influence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors. J Clin Oncol. 1984 Aug;2(8):917–923. doi: 10.1200/JCO.1984.2.8.917. [DOI] [PubMed] [Google Scholar]
  4. Lennox E. L., Stiller C. A., Jones P. H., Wilson L. M. Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J. 1979 Sep 8;2(6190):567–569. doi: 10.1136/bmj.2.6190.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Meadows A. T., Kramer S., Hopson R., Lustbader E., Jarrett P., Evans A. E. Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest. 1983;1(1):49–55. doi: 10.3109/07357908309040932. [DOI] [PubMed] [Google Scholar]
  6. Pritchard J., Stiller C. A., Lennox E. L. Overtreatment of children with Wilms' tumour outside paediatric oncology centres. BMJ. 1989 Sep 30;299(6703):835–836. doi: 10.1136/bmj.299.6703.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sanders B. M., Draper G. J., Kingston J. E. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988 Aug;72(8):576–583. doi: 10.1136/bjo.72.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Smith R., Fuller D. J., Wedge J. H., Williamson D. H., Alberti K. G. Initial effect of injury on ketone bodies and other blood metabolites. Lancet. 1975 Jan 4;1(7897):1–3. doi: 10.1016/s0140-6736(75)92369-7. [DOI] [PubMed] [Google Scholar]
  9. Stiller C. A. Centralisation of treatment and survival rates for cancer. Arch Dis Child. 1988 Jan;63(1):23–30. doi: 10.1136/adc.63.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stiller C. A., Draper G. J. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989 May;64(5):657–661. doi: 10.1136/adc.64.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES